The latest closing stock price for Oramed Pharmaceuticals as of April 22, 2025 is 2.29.
An investor who bought $1,000 worth of Oramed Pharmaceuticals stock at the IPO in 2004 would have $11,596 today, roughly 12 times their original investment - a 12.82% compound annual growth rate over 21 years.
The all-time high Oramed Pharmaceuticals stock closing price was 29.75 on November 08, 2021.
The Oramed Pharmaceuticals 52-week high stock price is 3.09, which is 34.9% above the current share price.
The Oramed Pharmaceuticals 52-week low stock price is 1.82, which is 20.5% below the current share price.
The average Oramed Pharmaceuticals stock price for the last 52 weeks is 2.35.
An investor who bought $1,000 worth of Oramed Pharmaceuticals stock at the IPO in 2004 would have $11,596 today, roughly 12 times their original investment - a 12.82% compound annual growth rate over 21 years.
The all-time high Oramed Pharmaceuticals stock closing price was 29.75 on November 08, 2021.
The Oramed Pharmaceuticals 52-week high stock price is 3.09, which is 34.9% above the current share price.
The Oramed Pharmaceuticals 52-week low stock price is 1.82, which is 20.5% below the current share price.
The average Oramed Pharmaceuticals stock price for the last 52 weeks is 2.35.